ProAssurance (PRA) – Analysts’ Recent Ratings Changes

ProAssurance (NYSE: PRA) has recently received a number of price target changes and ratings updates:

• 4/17/2025 – ProAssurance is now covered by analysts at StockNews.com. They set a “hold” rating on the stock.
• 4/10/2025 – ProAssurance was downgraded by analysts at Raymond James from a “market perform” rating to an “underperform” rating.
• 4/9/2025 – ProAssurance is now covered by analysts at StockNews.com. They set a “hold” rating on the stock.
• 4/3/2025 – ProAssurance was downgraded by analysts at Citigroup Inc. to a “market perform” rating.
• 4/3/2025 – ProAssurance was downgraded by analysts at Citizens Jmp from an “outperform” rating to a “market perform” rating.
• 4/1/2025 – ProAssurance is now covered by analysts at StockNews.com. They set a “hold” rating on the stock.
• 3/21/2025 – ProAssurance was downgraded by analysts at StockNews.com from a “buy” rating to a “hold” rating.
• 3/6/2025 – ProAssurance was upgraded by analysts at StockNews.com from a “hold” rating to a “buy” rating.
• 2/26/2025 – ProAssurance was downgraded by analysts at StockNews.com from a “buy” rating to a “hold” rating.

ProAssurance Stock Up 0.5 %

ProAssurance stock traded up $0.13 during mid-day trading on Tuesday, reaching $23.01. 199,730 shares of the company were exchanged, compared to its average volume of 415,386. The business has a fifty day moving average of $19.20 and a 200 day moving average of $16.91. ProAssurance Co. has a 12-month low of $10.76 and a 12-month high of $23.70. The company has a debt-to-equity ratio of 0.35, a quick ratio of 0.28 and a current ratio of 0.28. The firm has a market cap of $1.18 billion, a P/E ratio of 27.72 and a beta of -0.09.

ProAssurance (NYSE:PRA) last issued its earnings results on Monday, February 24th. The insurance provider reported $0.36 EPS for the quarter, beating analysts’ consensus estimates of $0.17 by $0.19. The firm had revenue of $287.52 million for the quarter, compared to analyst estimates of $274.56 million. ProAssurance had a return on equity of 2.65% and a net margin of 3.71%. Research analysts anticipate that ProAssurance Co. will post 0.8 earnings per share for the current fiscal year.

Institutional Trading of ProAssurance

Large investors have recently added to or reduced their stakes in the stock. Sterling Capital Management LLC increased its holdings in ProAssurance by 859.4% in the 4th quarter. Sterling Capital Management LLC now owns 1,631 shares of the insurance provider’s stock valued at $26,000 after purchasing an additional 1,461 shares during the last quarter. GAMMA Investing LLC grew its holdings in shares of ProAssurance by 307.3% in the first quarter. GAMMA Investing LLC now owns 2,073 shares of the insurance provider’s stock valued at $48,000 after purchasing an additional 1,564 shares in the last quarter. KBC Group NV lifted its holdings in ProAssurance by 75.4% during the 4th quarter. KBC Group NV now owns 4,184 shares of the insurance provider’s stock worth $67,000 after buying an additional 1,798 shares in the last quarter. Aquatic Capital Management LLC raised its stake in shares of ProAssurance by 148.6% in the fourth quarter. Aquatic Capital Management LLC now owns 6,214 shares of the insurance provider’s stock valued at $99,000 after acquiring an additional 3,714 shares in the last quarter. Finally, KLP Kapitalforvaltning AS purchased a new stake in shares of ProAssurance during the fourth quarter worth approximately $150,000. 85.58% of the stock is currently owned by hedge funds and other institutional investors.

ProAssurance Corporation, through its subsidiaries, provides property and casualty insurance, and reinsurance products in the United States. The company operates through Specialty Property and Casualty, Workers’ Compensation Insurance, and Segregated Portfolio Cell Reinsurance segments. It offers professional liability insurance to healthcare providers and institutions, and attorneys and their firms; medical technology liability insurance to medical technology and life sciences companies; and custom alternative risk solutions, including assumed reinsurance, loss portfolio transfers, and captive cell programs for healthcare professional liability insureds.